VolitionRx: Timothy Still

Epigenetics company Volition has appointed Timothy Still as chairman of the board. Still is currently chairman and CEO of Tstill Enterprises and an operating partner with Revival Healthcare. His most recent operating role was as president and CEO of Sense Biodetection, which merged with Sherlock Biosciences in early 2023. Prior to that, Still was a CEO and/or board member at numerous medical technology companies including Myoscience, MDx Health, Gold Standard Diagnostics, Global Kinetics, Xagenic, and Accumetrics. Earlier in his career, he held senior leadership roles at HemoSense, Cholestech, and Boehringer Mannheim/Roche. Still holds a master's degree in business administration from the University of Southern California and a bachelor of science degree from the University of California, Davis.